Name | Title | Contact Details |
---|
Dadson Manufacturing, Inc. is a Grain Valley, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Humana Military Healthcare Services, Inc. is a wholly-owned subsidiary of Humana Inc., one of the largest and most innovative health insurance companies in the country. Humana Military was founded in 1993 and is headquartered in Louisville, Kentucky
Iora Health is transforming health care, starting with primary care.
Hartford HealthCare is Connecticut`s most comprehensive healthcare network. With 33,000 employees and total operating revenue of $4.3 billion, Hartford HealthCare has cultivated a strong, unified culture of accountability and innovation. Its care-delivery system, serving 185 towns and cities at more than 400 locations, includes two tertiary-level teaching hospitals, an acute-care community teaching hospital, an acute-care hospital and trauma center, three community hospitals, the state`s most extensive behavioral health network, a large multispecialty physician group, a clinical care organization, a regional home care system, an array of senior care services, and a large physical therapy and rehabilitation network. Hartford HealthCare`s unique, systemwide Institute Model offers a single, high standard of care in crucial specialties at hospital and ambulatory sites across Connecticut. The institutes include: Cancer, Heart and Vascular, Neuroscience, Orthopedics and Urology.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.